FDA Device recall Z-2044-2023
RelieVR REF: RVX-2002, Rx Only
- FDA Device
- Class II
- completed
- Published 2023-07-05
On 2023-07-05 the FDA classified a Class II recall of RelieVR REF: RVX-2002, Rx Only by Appliedvr, citing there is the potential for the program software to malfunction which will not allow it to move forward to the next session.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2044-2023 |
| Classification | Class II |
| Status | completed |
| Initiated | 2023-02-27 |
| Published | 2023-07-05 |
| Last updated | 2026-09-13 11:56 UTC |
| Company | Appliedvr |
| Distribution | NY |
Product
RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.
Reason
There is the potential for the program software to malfunction which will not allow it to move forward to the next session.
Identifiers
| code_info | Serial Number: PA7940RGG5130514B; UDI: 0100850038247027211001077 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2044-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.